Yang VC - Search Results

1

Cell-penetrating peptide enhanced insulin buccal absorption.

Xu Y, Zhang X, Wang N, Pei X, Guo Y, Wang J, Barth S, Yu F, Lee SJ, He H, Yang VC. Xu Y, et al. Among authors: yang vc. Int J Pharm. 2020 Jun 30;584:119469. doi: 10.1016/j.ijpharm.2020.119469. Epub 2020 May 26. Int J Pharm. 2020. PMID: 32470482

2

Surface-modified poly(lactide-co-glycolide) nanospheres for targeted bone imaging with enhanced labeling and delivery of radioisotope.

Park YJ, Nah SH, Lee JY, Jeong JM, Chung JK, Lee MC, Yang VC, Lee SJ. Park YJ, et al. Among authors: yang vc. J Biomed Mater Res A. 2003 Dec 1;67(3):751-60. doi: 10.1002/jbm.a.10147. J Biomed Mater Res A. 2003. PMID: 14613222

3

Strategies for improving the functionality of an affinity bioreactor.

Wang T, Yang Z, Emregul E, David A, Balthasar JP, Liang J, Yang VC. Wang T, et al. Among authors: yang vc, yang z. Int J Pharm. 2005 Dec 8;306(1-2):132-41. doi: 10.1016/j.ijpharm.2005.09.011. Epub 2005 Oct 24. Int J Pharm. 2005. PMID: 16246511

4

Efficient labeling of mesenchymal stem cells using cell permeable magnetic nanoparticles.

Suh JS, Lee JY, Choi YS, Yu F, Yang V, Lee SJ, Chung CP, Park YJ. Suh JS, et al. Biochem Biophys Res Commun. 2009 Feb 13;379(3):669-75. doi: 10.1016/j.bbrc.2008.12.041. Epub 2008 Dec 25. Biochem Biophys Res Commun. 2009. PMID: 19101509

5

Specific down regulation of 3T3-L1 adipocyte differentiation by cell-permeable antisense HIF1alpha-oligonucleotide.

Park YS, Huang Y, Park YJ, David AE, White L, He H, Chung HS, Yang VC. Park YS, et al. Among authors: yang vc. J Control Release. 2010 May 21;144(1):82-90. doi: 10.1016/j.jconrel.2010.01.026. Epub 2010 Jan 28. J Control Release. 2010. PMID: 20109509 Free PMC article.

6

ATTEMPTS system: a macromolecular prodrug strategy for cancer drug delivery.

Huang Y, Park YS, Wang J, Moon C, Kwon YM, Chung HS, Park YJ, Yang VC. Huang Y, et al. Among authors: yang vc. Curr Pharm Des. 2010 Jul;16(21):2369-76. doi: 10.2174/138161210791920441. Curr Pharm Des. 2010. PMID: 20618157 Review.

7

Co-administration of protein drugs with gold nanoparticles to enable percutaneous delivery.

Huang Y, Yu F, Park YS, Wang J, Shin MC, Chung HS, Yang VC. Huang Y, et al. Among authors: yang vc. Biomaterials. 2010 Dec;31(34):9086-91. doi: 10.1016/j.biomaterials.2010.08.046. Epub 2010 Sep 9. Biomaterials. 2010. PMID: 20828812 Free PMC article.

8

Transcellular Transport of Heparin-coated Magnetic Iron Oxide Nanoparticles (Hep-MION) Under the Influence of an Applied Magnetic Field.

Min KA, Yu F, Yang VC, Zhang X, Rosania GR. Min KA, et al. Among authors: yang vc. Pharmaceutics. 2010 Apr 26;2(2):119-135. doi: 10.3390/pharmaceutics2020119. Pharmaceutics. 2010. PMID: 21152371 Free PMC article.

9

Polyethylene glycol modified, cross-linked starch-coated iron oxide nanoparticles for enhanced magnetic tumor targeting.

Cole AJ, David AE, Wang J, Galbán CJ, Hill HL, Yang VC. Cole AJ, et al. Among authors: yang vc. Biomaterials. 2011 Mar;32(8):2183-93. doi: 10.1016/j.biomaterials.2010.11.040. Epub 2010 Dec 21. Biomaterials. 2011. PMID: 21176955 Free PMC article.

10

Cell penetrating peptides for tumor targeting.

Choi YS, Lee JY, Suh JS, Lee SJ, Yang VC, Chung CP, Park YJ. Choi YS, et al. Among authors: yang vc. Curr Pharm Biotechnol. 2011 Aug;12(8):1166-82. doi: 10.2174/138920111796117391. Curr Pharm Biotechnol. 2011. PMID: 21470141 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

237 results

Search Page